Doi.org/10.1002/path.4254

Target Article

Utilising Pre-clinical Models to Refine Immune Modulation in Pancreatic Cancer  ; Thorsten Hagemann; NULL; 09/13/2013; https://doi.org/10.1002/path.4254

Reasons

Note: Reasons not yet here included, but you are welcome to insert this information whenever you wish.